UK markets closed
NIKKEI 225
37,628.48 -831.60 (-2.16%) HANG SENG
17,284.54 +83.27 (+0.48%) CRUDE OIL
82.54 -0.27 (-0.33%) GOLD FUTURES
2,342.60 +4.20 (+0.18%) DOW
37,938.88 -522.04 (-1.36%) Bitcoin GBP
51,246.20 -543.77 (-1.05%)
Simulations Plus, Inc. (SLP)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:12PM EDT. Market open.
| Previous close | 46.65 |
| Open | 45.88 |
| Bid | 45.47 x 100 |
| Ask | 45.60 x 100 |
| Day's range | 45.17 - 45.90 |
| 52-week range | 32.69 - 52.69 |
| Volume | |
| Avg. volume | 108,366 |
| Market cap | 910.012M |
| Beta (5Y monthly) | 0.71 |
| PE ratio (TTM) | 87.57 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.24 (0.51%) |
| Ex-dividend date | 26 Apr 2024 |
| 1y target est | N/A |
- Zacks
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
For the seventh consecutive year, the FDA has renewed Simulations Plus' (SLP) license to the DILIsym software system for facilitating drug safety evaluations.
- Simply Wall St.
Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year
Simulations Plus, Inc. ( NASDAQ:SLP ) investors will be delighted, with the company turning in some strong numbers with...
- Simply Wall St.
Simulations Plus Second Quarter 2024 Earnings: Beats Expectations
Simulations Plus ( NASDAQ:SLP ) Second Quarter 2024 Results Key Financial Results Revenue: US$18.3m (up 16% from 2Q...
© 2024 Yahoo. All rights reserved.